Belfast, NI – axial3D has announced additions to the leadership team as part of a rapid growth and expansion strategy.
In July, the company announced that it has successfully raised $3 million to further its existing reach into the US market. As part of this funding round, a number of senior appointments have been made to support this strategy.
Daniel Crawford, Founder of axial3D, has announced that as part of the next wave of development for the company, he will take on the post of Chief Strategy Officer and has appointed current board member Roger Johnston as CEO to bring additional experience and track record of rapidly scaling early-stage technology companies.
Roger brings a wealth of experience to axial3D, having held senior roles in a broad range of companies including Accenture, IBM, Meridio and most recently VP of Business Development for Kainos Digital Services.
“I am truly delighted to be taking up the post of CEO for axial3D. I’ve been engaged with the company as an advisor to the Board and investor for over a year and have been really impressed by the talent and enthusiasm of the team. This is one of the most exciting technology innovations that I have seen in my 33 years in IT and I am just so excited by its potential to changing the lives of patients around the world.”
The company has also appointed Rob Fisher to the role of VP of Business Development. Rob, who is based in the United States, brings significant clinical and business development experience in the USA and has held numerous senior roles over his 36 years in the healthcare industry, including most recently as Service Line Administrator at Tallahassee Memorial Healthcare and before that VP of Business Development for InTouch Health in California.
On his appointment, Rob said, “I am incredibly excited to be joining the axial3D team and taking responsibility for growing business, in particular here in the US. I worked with axial3D in Tallahassee Memorial Healthcare as a customer and directly saw the transformative impact that their 3D models can have on how surgeries are planned and how clinical outcomes can be transformed for patients. My aim is to help make axial3D a true market leader in this area.”
On his decision to make these changes, Daniel said, “Our recent investment round brought in over $3 million. This funding aims to rapidly expand our business in the US healthcare market while continuing to grow our excellent customer base here in the UK and Europe. Core to our growth strategy was to develop and build a fantastic team, enabling the company to scale. These leadership appointments are the first step in this process.”
“As Chief Strategy Officer I will be able to increase my time spent on the strategic direction of the business, specifically developing our unique pre-surgical planning offerings that enable every clinician we work with to improve the futures of their patients.”